Apex Infusion, a leading omnichannel infusion services provider, has entered into a definitive agreement to partner with SkyKnight Capital, L.P., a private equity firm with a track record of building industry-defining businesses alongside exceptional management teams, to drive the Company’s next chapter of growth. Apex’s clinician-led management team will retain a significant ownership stake and continue to lead the business. FFL Partners will also remain a minority investor in the company. The partnership is subject to customary closing conditions, including the receipt of required regulatory approvals.
Latham & Watkins LLP represented the private credit funds supporting the transaction with a team led by Stelios Saffos, Global Chair of Latham’s Capital Markets and Hybrid Capital practices, Alfred Xue, Global Vice Chair of the Banking & Private Credit Practice, and partners Abhay Lele and Josh Holt, with associates Julio Martinez Rivas and Cynthia Yang. Advice was also provided on tax matters by partner Bora Bozkurt, with associate James Aldred.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
